Somebody Had a Good Quarter!

NxStage company revenues were up 7% in Q4 of 2013 over 2012, and annual revenue was up 9% in 2013 over 2012. In the home dialysis market, revenues rose by 12%—however, the net loss per share was $0.31 in 2013 vs. 0.26 in 2012.

Read the full article » | Posted 03-07-2014

Related Articles

• Watch a 2-minute video of Dr. Brigitte Schiller describing a paper on nocturnal home HD Posted 08-21-2026
• The Quanta Dialysis System for home HD is the first FDA 510(k) approved machine that offers high (500 mL/min) dialysate flow Posted 08-21-2026
• The American Kidney Fund’s Kidney Action Week: Future of Kidney Care is September 8-10. Posted 08-21-2026
• On August 9, CMS published “Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment.” Posted 08-21-2026